Volume 15 (January 2008)
Osteogenesis and angiogenesis: The potential for engineering bone
Eur. Cell. Mater. 2008, 15, 100-114; https://doi.org/10.22203/eCM.v015a08
Properties of the amniotic membrane for potential use in tissue engineering
Eur. Cell. Mater. 2008, 15, 88-99; https://doi.org/10.22203/eCM.v015a07
Angiogenic competency of biodegradable hydrogels fabricated from polyethylene glycol-crosslinked tyrosine-derived polycarbonates
Eur. Cell. Mater. 2008, 15, 77-87; https://doi.org/10.22203/eCM.v015a06
Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts
Eur. Cell. Mater. 2008, 15, 53-76; https://doi.org/10.22203/eCM.v015a05
The use of fibrin and poly(lactic-co-glycolic acid) hybrid scaffold for articular cartilage tissue engineering: anin vivoanalysis
Eur. Cell. Mater. 2008, 15, 41-52; https://doi.org/10.22203/eCM.v015a04
Engineering vascularised tissuesin vitro
Eur. Cell. Mater. 2008, 15, 27-40; https://doi.org/10.22203/eCM.v015a03
ADAMTS-5: The story so far
Eur. Cell. Mater. 2008, 15, 11-26; https://doi.org/10.22203/eCM.v015a02
A low percentage of autologous serum can replace bovine serum to engineer human nasal cartilage
Eur. Cell. Mater. 2008, 15, 1-10; https://doi.org/10.22203/eCM.v015a01
Share

